The global Pharmaceutical Peptides Services market is projected to grow from US$ 5360 million in 2024 to US$ 8318.4 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.6% during the forecast period.

Pharmaceutical Peptides Services Market

Pharmaceutical peptides services refer to the range of services offered by pharmaceutical companies or specialized service providers for the development, production, and analysis of peptides for therapeutic purposes. These services typically include:

1. Peptide synthesis: Custom synthesis of peptides based on specific requirements, including the design and production of peptide libraries.

2. Peptide modification: Chemical modification of peptides to enhance their stability, bioavailability, or target specificity.

3. Peptide purification: Purification of synthesized peptides to remove impurities and obtain high-quality products.

4. Peptide characterization: Comprehensive analysis of peptides using techniques such as mass spectrometry, high-performance liquid chromatography (HPLC), and nuclear magnetic resonance (NMR) spectroscopy to determine their identity, purity, and structural properties.

5. Peptide formulation: Development of peptide formulations suitable for various administration routes, such as oral, injectable, or topical delivery.

6. Peptide stability studies: Evaluation of the stability of peptides under different conditions, including temperature, pH, and storage conditions, to ensure their shelf-life and efficacy.

7. Peptide bioassays: Testing the biological activity and efficacy of peptides using in vitro and in vivo models to assess their therapeutic potential.

8. Peptide scale-up: Scaling up the production of peptides from laboratory-scale to commercial-scale manufacturing, ensuring consistent quality and quantity.

9. Regulatory support: Assistance in navigating regulatory requirements and guidelines for the development and approval of peptide-based therapeutics.

10. Contract research and manufacturing: Collaborative partnerships or outsourcing of peptide-related research, development, and manufacturing activities to specialized service providers.

These services are essential for the discovery, development, and production of peptide-based drugs, which have gained significant attention in the pharmaceutical industry due to their high specificity, low toxicity, and potential for targeting various diseases.

Market Analysis and Insights: Global Pharmaceutical Peptides Services Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Pharmaceutical Peptides Services market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Pharmaceutical Peptides Services, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Pharmaceutical Peptides Services, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharmaceutical Peptides Services revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Pharmaceutical Peptides Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Pharmaceutical Peptides Services revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Pharmaceutical Peptides Services Market Report

Report Metric	Details
Report Name	Pharmaceutical Peptides Services Market
Accounted market size in 2024	US$ 5360 in million
Forecasted market size in 2030	US$ 8318.4 million
CAGR	7.6
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Peptide Drug Discovery Peptide Drug Bioconjugations Peptide Lead Optimization Formulation Development Peptide Drug Screening Service Total Peptide Library Construction Technology Other
Segment by Application	Enterprise Research Institute
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Creative Peptides, AmbioPharm, 3B Pharmaceuticals, ISSAR Pharma, Peptide Institute, WuXi AppTec, JPT Peptide Technologies, CPC Scientific, Red Glead Discovery, Eurofins Scientific, Bio-Synthesis, Bio Basic, CordenPharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Pharmaceutical Peptides Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Peptides Services companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Peptides Services revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Pharmaceutical Peptides Services Market growing?

Ans: The Pharmaceutical Peptides Services Market witnessing a CAGR of 7.6 during the forecast period 2024-2030.

What is the Pharmaceutical Peptides Services Market size in 2030?

Ans: The Pharmaceutical Peptides Services Market size in 2030 will be US$ 8318.4 million.

Who are the main players in the Pharmaceutical Peptides Services Market report?

Ans: The main players in the Pharmaceutical Peptides Services Market are Creative Peptides, AmbioPharm, 3B Pharmaceuticals, ISSAR Pharma, Peptide Institute, WuXi AppTec, JPT Peptide Technologies, CPC Scientific, Red Glead Discovery, Eurofins Scientific, Bio-Synthesis, Bio Basic, CordenPharma

What are the Application segmentation covered in the Pharmaceutical Peptides Services Market report?

Ans: The Applications covered in the Pharmaceutical Peptides Services Market report are Enterprise, Research Institute

What are the Type segmentation covered in the Pharmaceutical Peptides Services Market report?

Ans: The Types covered in the Pharmaceutical Peptides Services Market report are Peptide Drug Discovery, Peptide Drug Bioconjugations, Peptide Lead Optimization, Formulation Development, Peptide Drug Screening Service, Total Peptide Library Construction Technology, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pharmaceutical Peptides Services Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Peptide Drug Discovery

1.2.3 Peptide Drug Bioconjugations

1.2.4 Peptide Lead Optimization

1.2.5 Formulation Development

1.2.6 Peptide Drug Screening Service

1.2.7 Total Peptide Library Construction Technology

1.2.8 Other

1.3 Market by Application

1.3.1 Global Pharmaceutical Peptides Services Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Enterprise

1.3.3 Research Institute

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pharmaceutical Peptides Services Market Perspective (2019-2030)

2.2 Global Pharmaceutical Peptides Services Growth Trends by Region

2.2.1 Pharmaceutical Peptides Services Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Pharmaceutical Peptides Services Historic Market Size by Region (2019-2024)

2.2.3 Pharmaceutical Peptides Services Forecasted Market Size by Region (2025-2030)

2.3 Pharmaceutical Peptides Services Market Dynamics

2.3.1 Pharmaceutical Peptides Services Industry Trends

2.3.2 Pharmaceutical Peptides Services Market Drivers

2.3.3 Pharmaceutical Peptides Services Market Challenges

2.3.4 Pharmaceutical Peptides Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Pharmaceutical Peptides Services by Players

3.1.1 Global Pharmaceutical Peptides Services Revenue by Players (2019-2024)

3.1.2 Global Pharmaceutical Peptides Services Revenue Market Share by Players (2019-2024)

3.2 Global Pharmaceutical Peptides Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Pharmaceutical Peptides Services, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Pharmaceutical Peptides Services Market Concentration Ratio

3.4.1 Global Pharmaceutical Peptides Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Peptides Services Revenue in 2023

3.5 Global Key Players of Pharmaceutical Peptides Services Head office and Area Served

3.6 Global Key Players of Pharmaceutical Peptides Services, Product and Application

3.7 Global Key Players of Pharmaceutical Peptides Services, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmaceutical Peptides Services Breakdown Data by Type

4.1 Global Pharmaceutical Peptides Services Historic Market Size by Type (2019-2024)

4.2 Global Pharmaceutical Peptides Services Forecasted Market Size by Type (2025-2030)

5 Pharmaceutical Peptides Services Breakdown Data by Application

5.1 Global Pharmaceutical Peptides Services Historic Market Size by Application (2019-2024)

5.2 Global Pharmaceutical Peptides Services Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Pharmaceutical Peptides Services Market Size (2019-2030)

6.2 North America Pharmaceutical Peptides Services Market Size by Type

6.2.1 North America Pharmaceutical Peptides Services Market Size by Type (2019-2024)

6.2.2 North America Pharmaceutical Peptides Services Market Size by Type (2025-2030)

6.2.3 North America Pharmaceutical Peptides Services Market Share by Type (2019-2030)

6.3 North America Pharmaceutical Peptides Services Market Size by Application

6.3.1 North America Pharmaceutical Peptides Services Market Size by Application (2019-2024)

6.3.2 North America Pharmaceutical Peptides Services Market Size by Application (2025-2030)

6.3.3 North America Pharmaceutical Peptides Services Market Share by Application (2019-2030)

6.4 North America Pharmaceutical Peptides Services Market Size by Country

6.4.1 North America Pharmaceutical Peptides Services Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Pharmaceutical Peptides Services Market Size by Country (2019-2024)

6.4.3 North America Pharmaceutical Peptides Services Market Size by Country (2025-2030)

6.4.4 United States

6.4.5 Canada

7 Europe

7.1 Europe Pharmaceutical Peptides Services Market Size (2019-2030)

7.2 Europe Pharmaceutical Peptides Services Market Size by Type

7.2.1 Europe Pharmaceutical Peptides Services Market Size by Type (2019-2024)

7.2.2 Europe Pharmaceutical Peptides Services Market Size by Type (2025-2030)

7.2.3 Europe Pharmaceutical Peptides Services Market Share by Type (2019-2030)

7.3 Europe Pharmaceutical Peptides Services Market Size by Application

7.3.1 Europe Pharmaceutical Peptides Services Market Size by Application (2019-2024)

7.3.2 Europe Pharmaceutical Peptides Services Market Size by Application (2025-2030)

7.3.3 Europe Pharmaceutical Peptides Services Market Share by Application (2019-2030)

7.4 Europe Pharmaceutical Peptides Services Market Size by Country

7.4.1 Europe Pharmaceutical Peptides Services Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Pharmaceutical Peptides Services Market Size by Country (2019-2024)

7.4.3 Europe Pharmaceutical Peptides Services Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Pharmaceutical Peptides Services Market Size (2019-2030)

8.2 China Pharmaceutical Peptides Services Market Size by Type

8.2.1 China Pharmaceutical Peptides Services Market Size by Type (2019-2024)

8.2.2 China Pharmaceutical Peptides Services Market Size by Type (2025-2030)

8.2.3 China Pharmaceutical Peptides Services Market Share by Type (2019-2030)

8.3 China Pharmaceutical Peptides Services Market Size by Application

8.3.1 China Pharmaceutical Peptides Services Market Size by Application (2019-2024)

8.3.2 China Pharmaceutical Peptides Services Market Size by Application (2025-2030)

8.3.3 China Pharmaceutical Peptides Services Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Pharmaceutical Peptides Services Market Size (2019-2030)

9.2 Asia Pharmaceutical Peptides Services Market Size by Type

9.2.1 Asia Pharmaceutical Peptides Services Market Size by Type (2019-2024)

9.2.2 Asia Pharmaceutical Peptides Services Market Size by Type (2025-2030)

9.2.3 Asia Pharmaceutical Peptides Services Market Share by Type (2019-2030)

9.3 Asia Pharmaceutical Peptides Services Market Size by Application

9.3.1 Asia Pharmaceutical Peptides Services Market Size by Application (2019-2024)

9.3.2 Asia Pharmaceutical Peptides Services Market Size by Application (2025-2030)

9.3.3 Asia Pharmaceutical Peptides Services Market Share by Application (2019-2030)

9.4 Asia Pharmaceutical Peptides Services Market Size by Region

9.4.1 Asia Pharmaceutical Peptides Services Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Pharmaceutical Peptides Services Market Size by Region (2019-2024)

9.4.3 Asia Pharmaceutical Peptides Services Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Pharmaceutical Peptides Services Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Pharmaceutical Peptides Services Market Size by Type

10.2.1 Middle East, Africa, and Latin America Pharmaceutical Peptides Services Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Pharmaceutical Peptides Services Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Pharmaceutical Peptides Services Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Pharmaceutical Peptides Services Market Size by Application

10.3.1 Middle East, Africa, and Latin America Pharmaceutical Peptides Services Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Pharmaceutical Peptides Services Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Pharmaceutical Peptides Services Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Pharmaceutical Peptides Services Market Size by Country

10.4.1 Middle East, Africa, and Latin America Pharmaceutical Peptides Services Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Pharmaceutical Peptides Services Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Pharmaceutical Peptides Services Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Creative Peptides

11.1.1 Creative Peptides Company Details

11.1.2 Creative Peptides Business Overview

11.1.3 Creative Peptides Pharmaceutical Peptides Services Introduction

11.1.4 Creative Peptides Revenue in Pharmaceutical Peptides Services Business (2019-2024)

11.1.5 Creative Peptides Recent Developments

11.2 AmbioPharm

11.2.1 AmbioPharm Company Details

11.2.2 AmbioPharm Business Overview

11.2.3 AmbioPharm Pharmaceutical Peptides Services Introduction

11.2.4 AmbioPharm Revenue in Pharmaceutical Peptides Services Business (2019-2024)

11.2.5 AmbioPharm Recent Developments

11.3 3B Pharmaceuticals

11.3.1 3B Pharmaceuticals Company Details

11.3.2 3B Pharmaceuticals Business Overview

11.3.3 3B Pharmaceuticals Pharmaceutical Peptides Services Introduction

11.3.4 3B Pharmaceuticals Revenue in Pharmaceutical Peptides Services Business (2019-2024)

11.3.5 3B Pharmaceuticals Recent Developments

11.4 ISSAR Pharma

11.4.1 ISSAR Pharma Company Details

11.4.2 ISSAR Pharma Business Overview

11.4.3 ISSAR Pharma Pharmaceutical Peptides Services Introduction

11.4.4 ISSAR Pharma Revenue in Pharmaceutical Peptides Services Business (2019-2024)

11.4.5 ISSAR Pharma Recent Developments

11.5 Peptide Institute

11.5.1 Peptide Institute Company Details

11.5.2 Peptide Institute Business Overview

11.5.3 Peptide Institute Pharmaceutical Peptides Services Introduction

11.5.4 Peptide Institute Revenue in Pharmaceutical Peptides Services Business (2019-2024)

11.5.5 Peptide Institute Recent Developments

11.6 WuXi AppTec

11.6.1 WuXi AppTec Company Details

11.6.2 WuXi AppTec Business Overview

11.6.3 WuXi AppTec Pharmaceutical Peptides Services Introduction

11.6.4 WuXi AppTec Revenue in Pharmaceutical Peptides Services Business (2019-2024)

11.6.5 WuXi AppTec Recent Developments

11.7 JPT Peptide Technologies

11.7.1 JPT Peptide Technologies Company Details

11.7.2 JPT Peptide Technologies Business Overview

11.7.3 JPT Peptide Technologies Pharmaceutical Peptides Services Introduction

11.7.4 JPT Peptide Technologies Revenue in Pharmaceutical Peptides Services Business (2019-2024)

11.7.5 JPT Peptide Technologies Recent Developments

11.8 CPC Scientific

11.8.1 CPC Scientific Company Details

11.8.2 CPC Scientific Business Overview

11.8.3 CPC Scientific Pharmaceutical Peptides Services Introduction

11.8.4 CPC Scientific Revenue in Pharmaceutical Peptides Services Business (2019-2024)

11.8.5 CPC Scientific Recent Developments

11.9 Red Glead Discovery

11.9.1 Red Glead Discovery Company Details

11.9.2 Red Glead Discovery Business Overview

11.9.3 Red Glead Discovery Pharmaceutical Peptides Services Introduction

11.9.4 Red Glead Discovery Revenue in Pharmaceutical Peptides Services Business (2019-2024)

11.9.5 Red Glead Discovery Recent Developments

11.10 Eurofins Scientific

11.10.1 Eurofins Scientific Company Details

11.10.2 Eurofins Scientific Business Overview

11.10.3 Eurofins Scientific Pharmaceutical Peptides Services Introduction

11.10.4 Eurofins Scientific Revenue in Pharmaceutical Peptides Services Business (2019-2024)

11.10.5 Eurofins Scientific Recent Developments

11.11 Bio-Synthesis

11.11.1 Bio-Synthesis Company Details

11.11.2 Bio-Synthesis Business Overview

11.11.3 Bio-Synthesis Pharmaceutical Peptides Services Introduction

11.11.4 Bio-Synthesis Revenue in Pharmaceutical Peptides Services Business (2019-2024)

11.11.5 Bio-Synthesis Recent Developments

11.12 Bio Basic

11.12.1 Bio Basic Company Details

11.12.2 Bio Basic Business Overview

11.12.3 Bio Basic Pharmaceutical Peptides Services Introduction

11.12.4 Bio Basic Revenue in Pharmaceutical Peptides Services Business (2019-2024)

11.12.5 Bio Basic Recent Developments

11.13 CordenPharma

11.13.1 CordenPharma Company Details

11.13.2 CordenPharma Business Overview

11.13.3 CordenPharma Pharmaceutical Peptides Services Introduction

11.13.4 CordenPharma Revenue in Pharmaceutical Peptides Services Business (2019-2024)

11.13.5 CordenPharma Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

JPT Peptide Technologies

List of Tables

Table 1. Global Pharmaceutical Peptides Services Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Peptide Drug Discovery

Table 3. Key Players of Peptide Drug Bioconjugations

Table 4. Key Players of Peptide Lead Optimization

Table 5. Key Players of Formulation Development

Table 6. Key Players of Peptide Drug Screening Service

Table 7. Key Players of Total Peptide Library Construction Technology

Table 8. Key Players of Other

Table 9. Global Pharmaceutical Peptides Services Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 10. Global Pharmaceutical Peptides Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 11. Global Pharmaceutical Peptides Services Market Size by Region (2019-2024) & (US$ Million)

Table 12. Global Pharmaceutical Peptides Services Market Share by Region (2019-2024)

Table 13. Global Pharmaceutical Peptides Services Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 14. Global Pharmaceutical Peptides Services Market Share by Region (2025-2030)

Table 15. Pharmaceutical Peptides Services Market Trends

Table 16. Pharmaceutical Peptides Services Market Drivers

Table 17. Pharmaceutical Peptides Services Market Challenges

Table 18. Pharmaceutical Peptides Services Market Restraints

Table 19. Global Pharmaceutical Peptides Services Revenue by Players (2019-2024) & (US$ Million)

Table 20. Global Pharmaceutical Peptides Services Revenue Share by Players (2019-2024)

Table 21. Global Top Pharmaceutical Peptides Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Peptides Services as of 2023)

Table 22. Global Pharmaceutical Peptides Services Industry Ranking 2022 VS 2023 VS 2024

Table 23. Global 5 Largest Players Market Share by Pharmaceutical Peptides Services Revenue (CR5 and HHI) & (2019-2024)

Table 24. Global Key Players of Pharmaceutical Peptides Services, Headquarters and Area Served

Table 25. Global Key Players of Pharmaceutical Peptides Services, Product and Application

Table 26. Global Key Players of Pharmaceutical Peptides Services, Product and Application

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Pharmaceutical Peptides Services Market Size by Type (2019-2024) & (US$ Million)

Table 29. Global Pharmaceutical Peptides Services Revenue Market Share by Type (2019-2024)

Table 30. Global Pharmaceutical Peptides Services Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 31. Global Pharmaceutical Peptides Services Revenue Market Share by Type (2025-2030)

Table 32. Global Pharmaceutical Peptides Services Market Size by Application (2019-2024) & (US$ Million)

Table 33. Global Pharmaceutical Peptides Services Revenue Share by Application (2019-2024)

Table 34. Global Pharmaceutical Peptides Services Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 35. Global Pharmaceutical Peptides Services Revenue Share by Application (2025-2030)

Table 36. North America Pharmaceutical Peptides Services Market Size by Type (2019-2024) & (US$ Million)

Table 37. North America Pharmaceutical Peptides Services Market Size by Type (2025-2030) & (US$ Million)

Table 38. North America Pharmaceutical Peptides Services Market Size by Application (2019-2024) & (US$ Million)

Table 39. North America Pharmaceutical Peptides Services Market Size by Application (2025-2030) & (US$ Million)

Table 40. North America Pharmaceutical Peptides Services Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. North America Pharmaceutical Peptides Services Market Size by Country (2019-2024) & (US$ Million)

Table 42. North America Pharmaceutical Peptides Services Market Size by Country (2025-2030) & (US$ Million)

Table 43. Europe Pharmaceutical Peptides Services Market Size by Type (2019-2024) & (US$ Million)

Table 44. Europe Pharmaceutical Peptides Services Market Size by Type (2025-2030) & (US$ Million)

Table 45. Europe Pharmaceutical Peptides Services Market Size by Application (2019-2024) & (US$ Million)

Table 46. Europe Pharmaceutical Peptides Services Market Size by Application (2025-2030) & (US$ Million)

Table 47. Europe Pharmaceutical Peptides Services Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 48. Europe Pharmaceutical Peptides Services Market Size by Country (2019-2024) & (US$ Million)

Table 49. Europe Pharmaceutical Peptides Services Market Size by Country (2025-2030) & (US$ Million)

Table 50. China Pharmaceutical Peptides Services Market Size by Type (2019-2024) & (US$ Million)

Table 51. China Pharmaceutical Peptides Services Market Size by Type (2025-2030) & (US$ Million)

Table 52. China Pharmaceutical Peptides Services Market Size by Application (2019-2024) & (US$ Million)

Table 53. China Pharmaceutical Peptides Services Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Pharmaceutical Peptides Services Market Size by Type (2019-2024) & (US$ Million)

Table 55. Asia Pharmaceutical Peptides Services Market Size by Type (2025-2030) & (US$ Million)

Table 56. Asia Pharmaceutical Peptides Services Market Size by Application (2019-2024) & (US$ Million)

Table 57. Asia Pharmaceutical Peptides Services Market Size by Application (2025-2030) & (US$ Million)

Table 58. Asia Pharmaceutical Peptides Services Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 59. Asia Pharmaceutical Peptides Services Market Size by Region (2019-2024) & (US$ Million)

Table 60. Asia Pharmaceutical Peptides Services Market Size by Region (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Pharmaceutical Peptides Services Market Size by Type (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Pharmaceutical Peptides Services Market Size by Type (2025-2030) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Pharmaceutical Peptides Services Market Size by Application (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Pharmaceutical Peptides Services Market Size by Application (2025-2030) & (US$ Million)

Table 65. Middle East, Africa, and Latin America Pharmaceutical Peptides Services Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 66. Middle East, Africa, and Latin America Pharmaceutical Peptides Services Market Size by Country (2019-2024) & (US$ Million)

Table 67. Middle East, Africa, and Latin America Pharmaceutical Peptides Services Market Size by Country (2025-2030) & (US$ Million)

Table 68. Creative Peptides Company Details

Table 69. Creative Peptides Business Overview

Table 70. Creative Peptides Pharmaceutical Peptides Services Product

Table 71. Creative Peptides Revenue in Pharmaceutical Peptides Services Business (2019-2024) & (US$ Million)

Table 72. Creative Peptides Recent Developments

Table 73. AmbioPharm Company Details

Table 74. AmbioPharm Business Overview

Table 75. AmbioPharm Pharmaceutical Peptides Services Product

Table 76. AmbioPharm Revenue in Pharmaceutical Peptides Services Business (2019-2024) & (US$ Million)

Table 77. AmbioPharm Recent Developments

Table 78. 3B Pharmaceuticals Company Details

Table 79. 3B Pharmaceuticals Business Overview

Table 80. 3B Pharmaceuticals Pharmaceutical Peptides Services Product

Table 81. 3B Pharmaceuticals Revenue in Pharmaceutical Peptides Services Business (2019-2024) & (US$ Million)

Table 82. 3B Pharmaceuticals Recent Developments

Table 83. ISSAR Pharma Company Details

Table 84. ISSAR Pharma Business Overview

Table 85. ISSAR Pharma Pharmaceutical Peptides Services Product

Table 86. ISSAR Pharma Revenue in Pharmaceutical Peptides Services Business (2019-2024) & (US$ Million)

Table 87. ISSAR Pharma Recent Developments

Table 88. Peptide Institute Company Details

Table 89. Peptide Institute Business Overview

Table 90. Peptide Institute Pharmaceutical Peptides Services Product

Table 91. Peptide Institute Revenue in Pharmaceutical Peptides Services Business (2019-2024) & (US$ Million)

Table 92. Peptide Institute Recent Developments

Table 93. WuXi AppTec Company Details

Table 94. WuXi AppTec Business Overview

Table 95. WuXi AppTec Pharmaceutical Peptides Services Product

Table 96. WuXi AppTec Revenue in Pharmaceutical Peptides Services Business (2019-2024) & (US$ Million)

Table 97. WuXi AppTec Recent Developments

Table 98. JPT Peptide Technologies Company Details

Table 99. JPT Peptide Technologies Business Overview

Table 100. JPT Peptide Technologies Pharmaceutical Peptides Services Product

Table 101. JPT Peptide Technologies Revenue in Pharmaceutical Peptides Services Business (2019-2024) & (US$ Million)

Table 102. JPT Peptide Technologies Recent Developments

Table 103. CPC Scientific Company Details

Table 104. CPC Scientific Business Overview

Table 105. CPC Scientific Pharmaceutical Peptides Services Product

Table 106. CPC Scientific Revenue in Pharmaceutical Peptides Services Business (2019-2024) & (US$ Million)

Table 107. CPC Scientific Recent Developments

Table 108. Red Glead Discovery Company Details

Table 109. Red Glead Discovery Business Overview

Table 110. Red Glead Discovery Pharmaceutical Peptides Services Product

Table 111. Red Glead Discovery Revenue in Pharmaceutical Peptides Services Business (2019-2024) & (US$ Million)

Table 112. Red Glead Discovery Recent Developments

Table 113. Eurofins Scientific Company Details

Table 114. Eurofins Scientific Business Overview

Table 115. Eurofins Scientific Pharmaceutical Peptides Services Product

Table 116. Eurofins Scientific Revenue in Pharmaceutical Peptides Services Business (2019-2024) & (US$ Million)

Table 117. Eurofins Scientific Recent Developments

Table 118. Bio-Synthesis Company Details

Table 119. Bio-Synthesis Business Overview

Table 120. Bio-Synthesis Pharmaceutical Peptides Services Product

Table 121. Bio-Synthesis Revenue in Pharmaceutical Peptides Services Business (2019-2024) & (US$ Million)

Table 122. Bio-Synthesis Recent Developments

Table 123. Bio Basic Company Details

Table 124. Bio Basic Business Overview

Table 125. Bio Basic Pharmaceutical Peptides Services Product

Table 126. Bio Basic Revenue in Pharmaceutical Peptides Services Business (2019-2024) & (US$ Million)

Table 127. Bio Basic Recent Developments

Table 128. CordenPharma Company Details

Table 129. CordenPharma Business Overview

Table 130. CordenPharma Pharmaceutical Peptides Services Product

Table 131. CordenPharma Revenue in Pharmaceutical Peptides Services Business (2019-2024) & (US$ Million)

Table 132. CordenPharma Recent Developments

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Pharmaceutical Peptides Services Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Pharmaceutical Peptides Services Market Share by Type: 2023 VS 2030

Figure 3. Peptide Drug Discovery Features

Figure 4. Peptide Drug Bioconjugations Features

Figure 5. Peptide Lead Optimization Features

Figure 6. Formulation Development Features

Figure 7. Peptide Drug Screening Service Features

Figure 8. Total Peptide Library Construction Technology Features

Figure 9. Other Features

Figure 10. Global Pharmaceutical Peptides Services Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 11. Global Pharmaceutical Peptides Services Market Share by Application: 2023 VS 2030

Figure 12. Enterprise Case Studies

Figure 13. Research Institute Case Studies

Figure 14. Pharmaceutical Peptides Services Report Years Considered

Figure 15. Global Pharmaceutical Peptides Services Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Pharmaceutical Peptides Services Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Pharmaceutical Peptides Services Market Share by Region: 2023 VS 2030

Figure 18. Global Pharmaceutical Peptides Services Market Share by Players in 2023

Figure 19. Global Top Pharmaceutical Peptides Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Peptides Services as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Pharmaceutical Peptides Services Revenue in 2023

Figure 21. North America Pharmaceutical Peptides Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Pharmaceutical Peptides Services Market Share by Type (2019-2030)

Figure 23. North America Pharmaceutical Peptides Services Market Share by Application (2019-2030)

Figure 24. North America Pharmaceutical Peptides Services Market Share by Country (2019-2030)

Figure 25. United States Pharmaceutical Peptides Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Canada Pharmaceutical Peptides Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe Pharmaceutical Peptides Services Market Size YoY (2019-2030) & (US$ Million)

Figure 28. Europe Pharmaceutical Peptides Services Market Share by Type (2019-2030)

Figure 29. Europe Pharmaceutical Peptides Services Market Share by Application (2019-2030)

Figure 30. Europe Pharmaceutical Peptides Services Market Share by Country (2019-2030)

Figure 31. Germany Pharmaceutical Peptides Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. France Pharmaceutical Peptides Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. U.K. Pharmaceutical Peptides Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Italy Pharmaceutical Peptides Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Russia Pharmaceutical Peptides Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Nordic Countries Pharmaceutical Peptides Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. China Pharmaceutical Peptides Services Market Size YoY (2019-2030) & (US$ Million)

Figure 38. China Pharmaceutical Peptides Services Market Share by Type (2019-2030)

Figure 39. China Pharmaceutical Peptides Services Market Share by Application (2019-2030)

Figure 40. Asia Pharmaceutical Peptides Services Market Size YoY (2019-2030) & (US$ Million)

Figure 41. Asia Pharmaceutical Peptides Services Market Share by Type (2019-2030)

Figure 42. Asia Pharmaceutical Peptides Services Market Share by Application (2019-2030)

Figure 43. Asia Pharmaceutical Peptides Services Market Share by Region (2019-2030)

Figure 44. Japan Pharmaceutical Peptides Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. South Korea Pharmaceutical Peptides Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. China Taiwan Pharmaceutical Peptides Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Southeast Asia Pharmaceutical Peptides Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. India Pharmaceutical Peptides Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Australia Pharmaceutical Peptides Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America Pharmaceutical Peptides Services Market Size YoY (2019-2030) & (US$ Million)

Figure 51. Middle East, Africa, and Latin America Pharmaceutical Peptides Services Market Share by Type (2019-2030)

Figure 52. Middle East, Africa, and Latin America Pharmaceutical Peptides Services Market Share by Application (2019-2030)

Figure 53. Middle East, Africa, and Latin America Pharmaceutical Peptides Services Market Share by Country (2019-2030)

Figure 54. Brazil Pharmaceutical Peptides Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Mexico Pharmaceutical Peptides Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Turkey Pharmaceutical Peptides Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Saudi Arabia Pharmaceutical Peptides Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Israel Pharmaceutical Peptides Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. GCC Countries Pharmaceutical Peptides Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 60. Creative Peptides Revenue Growth Rate in Pharmaceutical Peptides Services Business (2019-2024)

Figure 61. AmbioPharm Revenue Growth Rate in Pharmaceutical Peptides Services Business (2019-2024)

Figure 62. 3B Pharmaceuticals Revenue Growth Rate in Pharmaceutical Peptides Services Business (2019-2024)

Figure 63. ISSAR Pharma Revenue Growth Rate in Pharmaceutical Peptides Services Business (2019-2024)

Figure 64. Peptide Institute Revenue Growth Rate in Pharmaceutical Peptides Services Business (2019-2024)

Figure 65. WuXi AppTec Revenue Growth Rate in Pharmaceutical Peptides Services Business (2019-2024)

Figure 66. JPT Peptide Technologies Revenue Growth Rate in Pharmaceutical Peptides Services Business (2019-2024)

Figure 67. CPC Scientific Revenue Growth Rate in Pharmaceutical Peptides Services Business (2019-2024)

Figure 68. Red Glead Discovery Revenue Growth Rate in Pharmaceutical Peptides Services Business (2019-2024)

Figure 69. Eurofins Scientific Revenue Growth Rate in Pharmaceutical Peptides Services Business (2019-2024)

Figure 70. Bio-Synthesis Revenue Growth Rate in Pharmaceutical Peptides Services Business (2019-2024)

Figure 71. Bio Basic Revenue Growth Rate in Pharmaceutical Peptides Services Business (2019-2024)

Figure 72. CordenPharma Revenue Growth Rate in Pharmaceutical Peptides Services Business (2019-2024)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-34A18264

Mon Nov 18 00:00:00 UTC 2024

Add to Cart

Global Custom Polyclonal Antibody Production Service Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-17I18806

Mon Nov 18 00:00:00 UTC 2024

Add to Cart

Cytogenetics Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-31E8575

Mon Nov 18 00:00:00 UTC 2024

Add to Cart

Automated Coagulation Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-21B8891

Mon Nov 18 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Pharmaceutical Peptides Services Market Insights, Forecast to 2030

Published Date: November 2024

Report Code: QYRE-Auto-31B12267

Global Pharmaceutical Peptides Services Market Insights, Forecast to 2030

FEATURED COMPANIES

Pharmaceutical Peptides Services Market Size

Pharmaceutical Peptides Services Market

Scope of Pharmaceutical Peptides Services Market Report

Chapter Outline

FAQ for this report

How fast is Pharmaceutical Peptides Services Market growing?

What is the Pharmaceutical Peptides Services Market size in 2030?

Who are the main players in the Pharmaceutical Peptides Services Market report?

What are the Application segmentation covered in the Pharmaceutical Peptides Services Market report?

What are the Type segmentation covered in the Pharmaceutical Peptides Services Market report?

FEATURED COMPANIES

RELATED REPORTS